Spray chemo shows promise for stomach cancer spread

NCT ID NCT06313801

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares standard chemotherapy alone versus chemotherapy plus a special procedure called PIPAC (pressurized intraperitoneal aerosol chemotherapy) for people with stomach cancer that has spread to the lining of the abdomen. About 106 adults aged 18-75 will take part. The goal is to see if adding PIPAC helps control the cancer longer and with fewer side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Institute of Clinical Oncology "Nizhny Novgorod Regional Clinical Oncological Dispensary", 11/1, Delovaya street, Nizhny Novgorod, 603126

    RECRUITING

    Nizhny Novgorod, 603126, Russia

    Contact Phone: •••-•••-•••• Email: •••••@•••••